Alzamend Neuro, Inc. ALZN
NASDAQ · United States · Health Technology
$1.32-0.42 (-23.99%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q1 2027 | 2026-09-10 | -0.68 | -0.56 | -21.4% | — | — | +2.4%$1.68→$1.72 |
| Q1 2026 | 2026-09-10 | -0.56 | -0.56 | 0.0% | $0 | — | +2.4%$1.68→$1.72 |
| Q4 2026 | 2026-07-22 | -0.74 | -0.67 | -10.4% | — | — | -4.5%$1.32→$1.26 |
| Q3 2026 | 2026-03-11 | -0.58 | -0.53 | -9.4% | — | — | -2.3%$2.14→$2.09 |
| Q2 2026 | 2025-12-09 | -0.30 | -1.95 | +84.6% | — | — | -4.0%$2.25→$2.16 |
| Q4 2025 | 2025-07-22 | -9.48 | -2.70 | -251.1% | — | — | — |
| Q3 2025 | 2025-03-10 | -1.71 | -3.19 | +46.4% | — | — | — |
| Q2 2025 | 2024-12-11 | -3.60 | -3.42 | -5.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.